Targeting ZEB2 By microRNA-129 In Non-Small Cell Lung Cancer Suppresses Cell Proliferation, Invasion And Migration...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide.
• MicroRNAs (miRNAs) are increasingly recognized for their critical roles in NSCLC pathogenesis.
• miR-129 is significantly downregulated in NSCLC tissues and cells, correlating with poor prognosis.

Purpose of the Study:

• To investigate the functional role of miR-129 in NSCLC progression.
• To elucidate the molecular mechanisms underlying miR-129's tumor-suppressive effects in NSCLC.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (QRT-PCR) to assess miR-129 expression in 51 NSCLC tissue samples.
• Kaplan-Meier analysis to correlate miR-129 levels with patient survival.
• Cell proliferation assays (MTT) and Transwell assays to evaluate miR-129's impact on NSCLC cell growth, migration, and invasion.

Main Results:

• miR-129 directly targets ZEB2 in NSCLC cell lines.
• Restoration of miR-129 expression inhibits epithelial-mesenchymal transition (EMT) and Wnt/β-catenin signaling pathways in NSCLC cells.

Conclusions:

• The miR-129/ZEB2 axis plays a crucial role in NSCLC development.
• miR-129 functions as a tumor suppressor in NSCLC.
• The miR-129/ZEB2 axis holds potential as a diagnostic and prognostic biomarker for NSCLC treatment.